Capital file / three-stage progression
A staged capital model showing what an institutional Seed, Expansion, and Series A path could unlock if the venture reaches the evidence required for each round.
This capital file is an illustrative founder planning document, not an offering memorandum, appraisal, financing commitment, or independently verified valuation. Competitor references and round figures are benchmark assumptions supplied for planning and should be re-validated during live diligence.
Secures lease and buildout of an 8,000 sq ft climate-controlled commercial greenhouse/warehouse facility, tissue culture lab, agricultural licensing, and automated packaging machinery.
8,000 sq ft Breeding Facility + Tissue Culture Lab + State Licenses.
$1.8M Gross Revenue (Wholesale Seed Packs & B2B Genetics Licensing).
35,000 sq ft production greenhouse expansion, multi-state commercial distribution nodes, and automated fulfillment center.
$6.5M Gross Revenue.
National multi-state B2B agricultural genetics dominance and global seed export licensing.
$20M+ Gross Revenue.
Commercial cannabis breeding labs and genetic IP brands (e.g., Phylos Bioscience, Humboldt Seed Company) raise $1.5M–$3M Seed capital to secure commercial real estate, build tissue culture labs, and acquire state/federal permits.
Use this request to identify yourself and the venture you are evaluating. Submission does not automatically disclose confidential material or establish an investment relationship. Access can be reviewed manually before any private documents are shared.